Home/Filings/4/0000885590-13-000060
4//SEC Filing

Valeant Pharmaceuticals International, Inc. 4

Accession 0000885590-13-000060

$BHCCIK 0000885590operating

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 4:55 PM ET

Size

5.2 KB

Accession

0000885590-13-000060

Insider Transaction Report

Form 4
Period: 2013-07-25
Weldon Ryan
EVP, Company Group Chairman
Transactions
  • Tax Payment

    Common Stock, no par values

    2013-07-2510263,438 total
Footnotes (2)
  • [F1]This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Matching Share Units.
  • [F2]This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.

Issuer

Valeant Pharmaceuticals International, Inc.

CIK 0000885590

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0000885590

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:55 PM ET
Size
5.2 KB